Integrative analysis of clinical and bioinformatics databases to identify anticancer properties of digoxin.
|アブストラクト||Cardiac glycosides, such as digoxin, inhibit Na(+)/K(+)-ATPases and cause secondary activation of Na(+)/Ca(2+) exchangers. Preclinical investigations have suggested that digoxin may have anticancer properties. In order to clarify the functional mechanisms of digoxin in cancer, we performed an integrative analysis of clinical and bioinformatics databases. The US Food and Drug Administration Adverse Event Reporting System and the Japan Medical Data Center claims database were used as clinical databases to evaluate reporting odds ratios and adjusted sequence ratios, respectively. The BaseSpace Correlation Engine and Connectivity Map bioinformatics databases were used to investigate molecular pathways related to digoxin anticancer mechanisms. |
Clinical database analyses suggested an inverse association between digoxin and four cancers: gastric, colon, prostate and haematological malignancy. The bioinformatics database analysis suggested digoxin may exert an anticancer effect via peroxisome proliferator-activated receptor alpha and apoptotic caspase cascade pathways. Our integrative analysis revealed the possibility of digoxin as a drug repositioning candidate for cancers.
|投稿者||Yokoyama, Satoshi; Sugimoto, Yasuhiro; Nakagawa, Chihiro; Hosomi, Kouichi; Takada, Mitsutaka|
|組織名||Division of Clinical Drug Informatics, School of Pharmacy, Kindai University,;3-4-1 Kowakae, Higashiosaka City, Osaka, 577-8502, Japan.;email@example.com.|